Home > Insider Trading > Filing (0001493152-21-031461)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1862150	Cingulate Inc.	CING	Pharmaceutical Preparations (2834)	863825535

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1883231	Jeffrey Thomas Hargroves	1901 W. 47Th Place Kansas City KS 66205		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-12-10	8,300	$0.00	8,300	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2021-12-10	8,300	$0.00	8,300	$6.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,300	2021-12-10	2026-12-10	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	37,543	Indirect	By Hargroves Family Investments, LLC

Footnotes

Reporting Person purchased 8,300 Units in the Issuer's initial public offering at $6.00 per Unit. Each Unit consists of one share of Common Stock and one warrant to purchase one share of Common Stock.
Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.